Accelerate Diagnostics
AXDX
NZ$0.05705
Share price
0.00%
Change (1 day)
-97.37%
Change (1 year)
Categories
Revenue for Accelerate Diagnostics (AXDX)
Revenue in 2024 (TTM): NZ$19.45 Million
According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM 
) is NZ$19.62 Million. an increase over the revenue in the year 2023 that were of NZ$19.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Accelerate Diagnostics from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$20.74 M | 8.78% |
| 2023 | NZ$19.06 M | -5.05% |
| 2022 | NZ$20.08 M | 16.44% |
| 2021 | NZ$17.24 M | 11.47% |
| 2020 | NZ$15.47 M | 12.08% |
| 2019 | NZ$13.8 M | 63.31% |
| 2018 | NZ$8.45 M | 43.76% |
| 2017 | NZ$5.88 M | 1555.7% |
| 2016 | NZ$0.35 M | 65.35% |
| 2015 | NZ$0.21 M | 37.94% |
| 2014 | NZ$0.15 M | 164.17% |
| 2013 | NZ$0.05 M | |
| 2011 | NZ$0.7 M | -81.58% |
| 2010 | NZ$3.83 M | 315.75% |
| 2009 | NZ$0.92 M | -43.12% |
| 2008 | NZ$1.62 M | 416% |
| 2007 | NZ$0.31 M | 4.4% |
| 2006 | NZ$0.3 M | -46% |
| 2005 | NZ$0.55 M | -16239.29% |
| 2004 | -NZ$0.01 Million | -100.43% |
| 2003 | NZ$0.79 M | -45.76% |
| 2002 | NZ$1.46 M | 17.05% |
| 2001 | NZ$1.25 M | -53.27% |
| 2000 | NZ$2.68 M | -43.16% |
| 1999 | NZ$4.71 M | -46.25% |
| 1998 | NZ$8.77 M | -12.68% |
| 1997 | NZ$10.05 M | 208.85% |
| 1996 | NZ$3.25 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | NZ$71.97 B | 366,612.26% | 🇺🇸 USA |
 PerkinElmer
PKI | NZ$5.63 B | 28,601.07% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$35.01 B | 178,280.92% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | NZ$4.26 B | 21,622.35% | 🇺🇸 USA |
 NanoString Technologies NSTG | NZ$0.27 B | 1,288.90% | 🇺🇸 USA |
 Bruker BRKR | NZ$5.78 B | 29,358.88% | 🇺🇸 USA |